attruby

BridgeBio secures $300 million from royalty financing, enhancing its financial position for Attruby® launch and pipeline development.

BridgeBio Pharma has secured a $300 million upfront payment through a royalty financing agreement with HealthCare Royalty and Blue Owl Capital, which will bolster…

Subscribe to